DE602004012448D1 - Morpholinylhaltige benzimidazole als inhibitoren der replikation von respiratory syncytial virus - Google Patents

Morpholinylhaltige benzimidazole als inhibitoren der replikation von respiratory syncytial virus

Info

Publication number
DE602004012448D1
DE602004012448D1 DE602004012448T DE602004012448T DE602004012448D1 DE 602004012448 D1 DE602004012448 D1 DE 602004012448D1 DE 602004012448 T DE602004012448 T DE 602004012448T DE 602004012448 T DE602004012448 T DE 602004012448T DE 602004012448 D1 DE602004012448 D1 DE 602004012448D1
Authority
DE
Germany
Prior art keywords
morpholinyl
replication
inhibitors
respiratory syncytial
syncytial virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004012448T
Other languages
English (en)
Other versions
DE602004012448T2 (de
Inventor
Jean-Francois Bonfanti
Koenraad Jozef Andries
Jerome Michel FORTIN
Philippe Muller
Frederic Marc Doublet
Christophe Meyer
Rudy Edmond Willebrords
Tom Valerius Gevers
Philip Maria Timmerman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen R&D Ireland ULC
Original Assignee
Tibotec Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34704695&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602004012448(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tibotec Pharmaceuticals Ltd filed Critical Tibotec Pharmaceuticals Ltd
Publication of DE602004012448D1 publication Critical patent/DE602004012448D1/de
Application granted granted Critical
Publication of DE602004012448T2 publication Critical patent/DE602004012448T2/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE602004012448T 2003-12-18 2004-12-20 Morpholinylhaltige benzimidazole als inhibitoren der replikation von respiratory syncytial virus Active DE602004012448T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP03104810 2003-12-18
EP03104810 2003-12-18
US56718204P 2004-04-30 2004-04-30
US567182P 2004-04-30
EP04105312 2004-10-26
EP04105312 2004-10-26
PCT/EP2004/053620 WO2005058871A1 (en) 2003-12-18 2004-12-20 Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication

Publications (2)

Publication Number Publication Date
DE602004012448D1 true DE602004012448D1 (de) 2008-04-24
DE602004012448T2 DE602004012448T2 (de) 2009-03-26

Family

ID=34704695

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004012448T Active DE602004012448T2 (de) 2003-12-18 2004-12-20 Morpholinylhaltige benzimidazole als inhibitoren der replikation von respiratory syncytial virus

Country Status (33)

Country Link
US (2) US7449463B2 (de)
EP (1) EP1697345B1 (de)
JP (1) JP4951348B2 (de)
KR (1) KR100967406B1 (de)
CN (2) CN101412709B (de)
AP (1) AP2150A (de)
AR (1) AR046959A1 (de)
AT (1) ATE388950T1 (de)
AU (1) AU2004298460B2 (de)
BR (1) BRPI0417268B8 (de)
CA (1) CA2548668C (de)
CY (1) CY1108142T1 (de)
DE (1) DE602004012448T2 (de)
DK (1) DK1697345T3 (de)
EA (1) EA009876B1 (de)
EG (1) EG25799A (de)
ES (1) ES2303653T3 (de)
HK (1) HK1130799A1 (de)
HR (1) HRP20080245T3 (de)
IL (1) IL175910A (de)
ME (1) ME01042B (de)
MX (1) MXPA06007112A (de)
MY (1) MY143573A (de)
NO (1) NO339314B1 (de)
NZ (1) NZ547479A (de)
PL (1) PL1697345T3 (de)
PT (1) PT1697345E (de)
RS (1) RS50584B (de)
SI (1) SI1697345T1 (de)
TW (1) TWI351401B (de)
UA (1) UA84718C2 (de)
WO (1) WO2005058871A1 (de)
ZA (1) ZA200605894B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR046959A1 (es) * 2003-12-18 2006-01-04 Tibotec Pharm Ltd Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio
TWI370820B (en) 2005-04-27 2012-08-21 Takeda Pharmaceutical Fused heterocyclic compounds
JP5078887B2 (ja) * 2005-06-20 2012-11-21 テイボテク・フアーマシユーチカルズ 呼吸器シンシチウムウイルスに活性をもつ、1−(2−アミノ−3−(置換アルキル)−3h−ベンズイミダゾイルメチル)−3−置換−1,3−ジヒドロ−ベンゾイミダゾル−2−オン
US8178694B2 (en) 2005-06-20 2012-05-15 Tibotec Pharmaceuticals Ltd. Heterocyclylaminoalkyl substituted benzimidazoles
US20120148678A1 (en) 2010-12-08 2012-06-14 Advanced Technologies And Regenerative Medicine, Llc. Sustained release of poorly water soluble active compounds
PL2766359T3 (pl) 2011-10-14 2016-11-30 Związki heterocykliczne i ich zastosowanie jako modulatorów receptorowych kinaz tyrozynowych typu iii
UA119050C2 (uk) * 2013-11-11 2019-04-25 Ґілеад Саєнсиз, Інк. ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ
JO3637B1 (ar) * 2015-04-28 2020-08-27 Janssen Sciences Ireland Uc مركبات بيرازولو- وترايازولو- بيريميدين مضادة للفيروسات rsv
EP3454897A4 (de) * 2016-05-10 2020-01-15 Georgia State University Research Foundation, Inc. Bicyclische kondensierte pyrazolderivate zur behandlung von rsv
TW201815787A (zh) 2016-09-23 2018-05-01 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201825465A (zh) 2016-09-23 2018-07-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201813963A (zh) 2016-09-23 2018-04-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
NZ748072A (en) 2017-03-20 2020-06-26 Forma Therapeutics Inc Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators
TW201932470A (zh) 2017-11-29 2019-08-16 愛爾蘭商健生科學愛爾蘭無限公司 具有抗rsv活性之吡唑并嘧啶
MX2020008061A (es) 2018-01-31 2020-09-09 Janssen Sciences Ireland Unlimited Co Pirazolopirimidinas sustituidas con cicloalquilo que tienen actividad contra vrs.
CA3095277A1 (en) 2018-04-23 2019-10-31 Janssen Sciences Ireland Unlimited Company Heteroaromatic compounds having activity against rsv
WO2020061255A1 (en) 2018-09-19 2020-03-26 Forma Therapeutics, Inc. Activating pyruvate kinase r
MA53668A (fr) 2018-09-19 2021-09-15 Forma Therapeutics Inc Traitement de la drépanocytose avec un composé activant la pyruvate kinase r
GB201820751D0 (en) * 2018-12-19 2019-01-30 Bp Oil Int Methods for preparing intermediates
EP4004002A1 (de) 2019-07-22 2022-06-01 Lupin Limited Makrocyclische verbindungen als sting-agonisten sowie verfahren und ihre verwendung
JP7329239B2 (ja) 2019-09-20 2023-08-18 株式会社タマディック フライトシミュレーター
WO2023018560A1 (en) * 2021-08-13 2023-02-16 Georgia State University Research Foundation, Inc. Bicyclic fused pyrazole derivatives for the treatment of respiratory infections including rsv

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL200694B1 (pl) * 1999-06-28 2009-01-30 Janssen Pharmaceutica Nv Pochodna benzoimidazolu lub imidazopirydyny, sposób jej otrzymywania i zastosowanie oraz kompozycja farmaceutyczna i sposób jej otrzymywania
ES2228559T3 (es) * 1999-06-28 2005-04-16 Janssen Pharmaceutica N.V. Inhibidores de la replicacion del virus respiratorio sincintial.
DE60008112T2 (de) * 1999-06-28 2004-09-16 Janssen Pharmaceutica N.V. Respiratorisches syncytialvirus replikation inhibitoren
AR046959A1 (es) * 2003-12-18 2006-01-04 Tibotec Pharm Ltd Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio
MY141292A (en) * 2003-12-18 2010-04-16 Tibotec Pharm Ltd Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication

Also Published As

Publication number Publication date
AU2004298460A1 (en) 2005-06-30
DE602004012448T2 (de) 2009-03-26
JP2007514720A (ja) 2007-06-07
HK1130799A1 (en) 2010-01-08
CA2548668C (en) 2011-09-20
NO20063322L (no) 2006-09-18
ATE388950T1 (de) 2008-03-15
AR046959A1 (es) 2006-01-04
EP1697345A1 (de) 2006-09-06
MXPA06007112A (es) 2006-08-23
ME01042B (me) 2012-10-20
SI1697345T1 (sl) 2008-08-31
TW200531972A (en) 2005-10-01
CY1108142T1 (el) 2014-02-12
ES2303653T3 (es) 2008-08-16
CA2548668A1 (en) 2005-06-30
AP2150A (en) 2010-09-04
AU2004298460B2 (en) 2009-03-19
IL175910A (en) 2013-08-29
PL1697345T3 (pl) 2008-08-29
PT1697345E (pt) 2008-06-12
BRPI0417268B1 (pt) 2018-10-23
US20070043022A1 (en) 2007-02-22
ZA200605894B (en) 2008-01-08
BRPI0417268B8 (pt) 2021-05-25
RS50584B (sr) 2010-05-07
JP4951348B2 (ja) 2012-06-13
DK1697345T3 (da) 2008-06-23
EG25799A (en) 2012-08-06
US7449463B2 (en) 2008-11-11
EA200601178A1 (ru) 2006-10-27
EP1697345B1 (de) 2008-03-12
NZ547479A (en) 2009-03-31
CN101412709A (zh) 2009-04-22
CN1894237A (zh) 2007-01-10
KR100967406B1 (ko) 2010-07-01
TWI351401B (en) 2011-11-01
IL175910A0 (en) 2006-10-05
CN101412709B (zh) 2015-03-25
KR20070015507A (ko) 2007-02-05
UA84718C2 (ru) 2008-11-25
NO339314B1 (no) 2016-11-28
AP2006003640A0 (en) 2006-06-30
WO2005058871A1 (en) 2005-06-30
EA009876B1 (ru) 2008-04-28
US20080280881A1 (en) 2008-11-13
HRP20080245T3 (en) 2008-07-31
MY143573A (en) 2011-05-31
US8883837B2 (en) 2014-11-11
BRPI0417268A (pt) 2007-03-13

Similar Documents

Publication Publication Date Title
DE602004012448D1 (de) Morpholinylhaltige benzimidazole als inhibitoren der replikation von respiratory syncytial virus
DK1723136T3 (da) Piperidinamino-benzimidazol-derivat som inhibitorer af replikation af respiratorisk syncytial virus
DE602005023266D1 (de) Azabenzofuransubstituierte thioharnstoffe als inhibitoren der virusreplikation
DK1928438T3 (da) Anvendelse af ibudilast til behandling af stofafhængighed
DK1817282T3 (da) Til behandling af respiratoriske sygdomme egnede phenoxy derivater
DK1633726T3 (da) Pyrimidinderivater, der er egnede til behandling af CRTH2-formidlede sygdomme
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
DK1877232T3 (da) Fremgangsmåde til behandling af træoverflader
DK1937633T3 (da) Biphenyloxyeddikesyrederivater til behandling af respiratoriske sygdomme
DK1776136T3 (da) Behandling af tilstande, der involverer demyelinisering
DK1830843T3 (da) Indolidon-derivater til behandling eller forebyggelse af fibrotiske sygdomme
DK1948176T3 (da) Diarylurinstoffer til behandling af pulmonær hypertension
ATE479673T1 (de) Hemmer der neubildung menschlicher immundefekt- viren
ATE521365T1 (de) Kinin-antagonisten zur behandlung von blasenfunktionsstörung
DK1611108T3 (da) Fremgangsmåde til fremstilling af telmisartan
DE602005017503D1 (de) Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
DE602005014646D1 (de) Substituierte propenylpiperazinderivate als neue inhibitoren von histondeacetylase
DE602004019208D1 (de) Neue benzimidazolderivate
NO20080412L (no) Ny fysiologisk forbindelse Nesfatin, forbindelse relevant dertil og anvendelse av forbindelsene
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
DK1856035T3 (da) Fremgangsmåde til fremstilling af beskyttelse amidiner
DK1697343T3 (da) Aminobenzimidazoler og benzimidazoler som inhibitorer af replikation af respiratorisk syncytialvirus
DK2366393T3 (da) Roflumilast til behandlingen af pulmonal hypertension
ATE441647T1 (de) N-amidderivate von 8-azabicycloä3.2.1üoct-3-yl als ccr1-antagonisten
ATE499361T1 (de) 5- oder 6-substituierte benzimidazolderivate als inhibitoren der replikation des respiratory syncytial virus

Legal Events

Date Code Title Description
8364 No opposition during term of opposition